Teacher Retirement System of Texas’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $246K | Sell |
7,756
-1,121
| -13% | -$30.6K | ﹤0.01% | 1360 |
|
|
2025
Q4 | $241K | Sell |
8,877
-5,821
| -40% | -$153K | ﹤0.01% | 1480 |
|
|
2025
Q3 | $380K | Sell |
14,698
-1,408
| -9% | -$32.6K | ﹤0.01% | 1636 |
|
|
2025
Q2 | $328K | Buy |
16,106
+35
| +0.2% | +$681 | ﹤0.01% | 1734 |
|
|
2025
Q1 | $292K | Sell |
16,071
-1,626
| -9% | -$36.3K | ﹤0.01% | 1754 |
|
|
2024
Q4 | $447K | Buy |
17,697
+2,819
| +19% | +$76.6K | ﹤0.01% | 1290 |
|
|
2024
Q3 | $506K | Buy |
14,878
+2,145
| +17% | +$81.7K | ﹤0.01% | 1204 |
|
|
2024
Q2 | $471K | Buy |
12,733
+53
| +0.4% | +$2K | ﹤0.01% | 1218 |
|
|
2024
Q1 | $532K | Buy |
12,680
+1,324
| +12% | +$54.4K | ﹤0.01% | 1251 |
|
|
2023
Q4 | $450K | Sell |
11,356
-44
| -0.4% | -$1.29K | ﹤0.01% | 1413 |
|
|
2023
Q3 | $314K | Buy |
11,400
+522
| +5% | +$16.4K | ﹤0.01% | 1574 |
|
|
2023
Q2 | $369K | Sell |
10,878
-730
| -6% | -$24.6K | ﹤0.01% | 1550 |
|
|
2023
Q1 | $418K | Buy |
11,608
+435
| +4% | +$18.8K | ﹤0.01% | 1560 |
|
|
2022
Q4 | $498K | Sell |
11,173
-1,123
| -9% | -$40.1K | ﹤0.01% | 1482 |
|
|
2022
Q3 | $346K | Buy |
+12,296
| New | +$377K | ﹤0.01% | 1686 |
|
|
2022
Q2 | – | Sell |
-7,745
| Closed | -$264K | – | 2017 |
|
|
2022
Q1 | $264K | Buy |
7,745
+594
| +8% | +$19K | ﹤0.01% | 1789 |
|
|
2021
Q4 | $276K | Buy |
7,151
+1,019
| +17% | +$44.4K | ﹤0.01% | 1834 |
|
|
2021
Q3 | $331K | Buy |
+6,132
| New | +$288K | ﹤0.01% | 1620 |
|
|
2018
Q2 | – | Sell |
-1,999
| Closed | -$70K | – | 1943 |
|
|
2018
Q1 | $70K | Sell |
1,999
-885
| -31% | -$34.3K | ﹤0.01% | 1916 |
|
|
2017
Q4 | $123K | Buy |
2,884
+2,206
| +325% | +$94.5K | ﹤0.01% | 2185 |
|
|
2017
Q3 | $29K | Buy |
+678
| New | +$25.4K | ﹤0.01% | 1150 |
|
|
2016
Q4 | – | Sell |
-697
| Closed | -$42K | – | 1081 |
|
|
2016
Q3 | $42K | Sell |
697
-210
| -23% | -$13.1K | ﹤0.01% | 1388 |
|
|
2016
Q2 | $60K | Buy |
907
+85
| +10% | +$5.4K | ﹤0.01% | 2126 |
|
|
2016
Q1 | $47K | Buy |
822
+212
| +35% | +$23.9K | ﹤0.01% | 2180 |
|
|
2015
Q4 | $143K | Sell |
610
-195
| -24% | -$42.5K | ﹤0.01% | 1375 |
|
|
2015
Q3 | $127K | Buy |
805
+558
| +226% | +$158K | ﹤0.01% | 1605 |
|
|
2015
Q2 | $94K | Buy |
247
+51
| +26% | +$20.3K | ﹤0.01% | 1186 |
|
|
2015
Q1 | $82K | Buy |
196
+15
| +8% | +$5.37K | ﹤0.01% | 1208 |
|
|
2014
Q4 | $49K | Sell |
181
-35
| -16% | -$8.7K | ﹤0.01% | 1340 |
|
|
2014
Q3 | $42K | Buy |
216
+5
| +2% | +$1.09K | ﹤0.01% | 1393 |
|
|
2014
Q2 | $52K | Hold |
211
| – | – | ﹤0.01% | 1371 |
|
|
2014
Q1 | $56K | Sell |
211
-8
| -4% | -$3.06K | ﹤0.01% | 1114 |
|
|
2013
Q4 | $80K | Sell |
219
-471
| -68% | -$181K | ﹤0.01% | 909 |
|
|
2013
Q3 | $367K | Buy |
690
+324
| +89% | +$111K | ﹤0.01% | 785 |
|
|
2013
Q2 | $86K | Buy |
+366
| New | +$72.1K | ﹤0.01% | 1293 |
|
Other funds holding CLDX
KCM
VCM
CC
EP
Teacher Retirement System of Texas's CLDX Position: Q1 2026 in Review
Teacher Retirement System of Texas reduced its Celldex Therapeutics (CLDX) stake by 13% in Q1 2026, selling an estimated $30.6K and leaving 7,756 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #1360.
Teacher Retirement System of Texas first reported a position in CLDX in Q2 2013 and has held it in 35 quarters since. The position peaked at $532K in Q1 2024. 228 funds tracked by Wall St. Rank hold CLDX as of Q1 2026.
- Teacher Retirement System of Texas held 7,756 shares of Celldex Therapeutics worth $246K as of Q1 2026.
- Teacher Retirement System of Texas sold 1,121 Celldex Therapeutics shares in Q1 2026, an estimated $30.6K.
- Celldex Therapeutics made up ﹤0.01% of Teacher Retirement System of Texas's portfolio in Q1 2026, its #1360 holding.
- Teacher Retirement System of Texas first reported a position in Celldex Therapeutics in Q2 2013 and has held it in 35 quarters since.
- Teacher Retirement System of Texas's Celldex Therapeutics position peaked at $532K in Q1 2024.
- 228 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q1 2026.
Based on Teacher Retirement System of Texas's 13F filing for Q1 2026, filed 30 Apr 2026.